Adequate capacity — beds, equipment, consumables, and, crucially, trained personnel — is needed to cope with a surge of critically ill patients
In this issue of the MJA, Burrell and his co‐authors report on the management and outcomes of patients with coronavirus disease 2019 (COVID‐19) admitted to Australian intensive care units (ICUs) during February–June 2020.1 The ICU mortality rate was impressively low (22% for patients requiring mechanical ventilation, 5% for those who did not). Given the excellent quality of care, it is worth exploring other reasons for this low mortality.
Please login with your free MJA account to view this article in full
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
I was involved with UCL, the UCL Hospitals NHS Foundation Trust, and Mercedes F1 in the development of a CPAP device (UCL Ventura) for use in patients with COVID‐19 on a not‐for profit, humanitarian basis.